Transglutaminase Market By Product Type (Microbial Transglutaminase, Mammalian Transglutaminase); By Application (Food & Beverage (Meat & Fish Processing, Dairy Products, Bakery & Confectionery, Plant-Based Products), Pharmaceuticals, Cosmetics, Others); By Form (Powder, Liquid); By Distribution Channel (Direct Sales, Distributors, Online Platforms); By Geography, Segment revenue estimation, Forecast, 2024–2032.

The transglutaminase market was USD 500 million in 2023 and is expected to grow to USD 800 million by 2030 at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period. The market growth is due to rising consumption in the food industry, focusing on the meat, dairy, and bakery sectors, as well as new solutions for the pharmaceutical and cosmetics industries.

 

Transglutaminase, commonly known as TGase, is an enzyme used in various sectors, including food, pharmaceuticals, and cosmetics. It fosters protein cross-linking and strengthens texture, stability, and elasticity in several uses. Its versatility in advancing product efficiency without necessarily increasing cost has been the reason for its commercial success in many industries.

 

Market Drivers

Rising Demand for Processed Foods: The application of transglutaminase has been highly attributed to the increasing global consumption of processed and ready-to-eat foods. Its ability to enhance the texture and consistency of products such as sausages, dairy, and bakery makes it indispensable. For example, the processed meat market in 2022 reached more than 300 billion USD worldwide, and the application of transglutaminase accelerates the binding and texture improvement.

 

Increasing Preference for Plant-Based Proteins: As more people adopt vegan diets and plant protein products, transglutaminase is finding its way into foods because it enhances the texture of plant-based meat products. The plant-based protein market was USD 14 billion in 2023 and is estimated to rise by 9% yearly, increasing the call for transglutaminase in food production.

 

Applications in Pharmaceuticals and Cosmetics: It is employed in dressing agents for wound healing, antiaging formulations, and other pharmaceutical uses because it acts as a protein cross-linking agent. Example: The functional use of the enzyme in bioadhesives for wound healing has been promising for further development in tissue engineering, for which clinical trials have commenced.

 

Market Opportunities

Expanding Applications in Non-Food Industries: The key markets for transglutaminase growth include the pharmaceuticals and cosmetics industries. Hence, the discovery of its applicability in drug delivery systems, tissue engineering and various formulations used in preparing skincare products is unprecedented. Example: Scientists in America are working on bioadhesives prepared from transglutaminase that can be used in MIS, an innovation that can transform the nature of the health industry.

 

Growth in Emerging Markets: At present, there is constantly increasing demand for processed foods in the Asian-Pacific region and Latin America. These dynamically developing countries have high rates of urbanization and are, thus, potential customers for transglutaminase. In 2023, the Asia-Pacific region shared 40% of processed food consumption worldwide, with China and India being the major consumers, experiencing consumption growth rates above 10%.

 

Focus on Sustainable Production: Potential: The transglutaminase manufacturing industries could capitalize on the fact that many industries are changing towards formalized and ecologically friendly methods of production.

 

Market Restraints

Regulatory Challenges: The stringent measures regulating the usage of enzymes in food and drugs and its impacts are the restraints that may affect the market development. For instance, approval for a new application on the Novel Food requires passing several tests and meeting the standards of FDA-USA and EFSA.

 

High Production Costs: Another limitation to using transglutaminase is that its production is undertaken through modern biotechnological procedures, which may be expensive, especially for the relatively small-scale producers.

 

Market Segmentation

By Product Type

• Microbial Transglutaminase

• Mammalian Transglutaminase

 

By Application

• Food & Beverage

  • Meat & Fish Processing

  • Dairy Products

  • Bakery & Confectionery

  • Plant-Based Products

• Pharmaceuticals

• Cosmetics

• Others

 

By Form

• Powder

• Liquid

 

By Distribution Channel

• Direct Sales

• Distributors

• Online Platforms

 

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Segment Analysis

Leading Product Type: Microbial Transglutaminase

Microbial transglutaminase has taken over the market due to its high performance, relatively low cost, and versatility in various industries. Example: Market share analysis revealed that microbial transglutaminase held over 60% of the industry share in the year 2023, leveraging more on the food processing industry.

 

Leading Application: Food & Beverage

The largest application of transglutaminase is in food and beverages, especially in meat, dairy, and bakery products. Example: By 2023, meat and fish processing will account for %40 of the total revenue for this segment due to the increasing popularity of textured products, especially in North America and Europe.

 

Regional Analysis

North America has the largest share owing to the increasing consumption of processed and convenience foods. It also has the highest value of R & D for pharmaceutical and cosmetics, and The U.S. consumed 25% of the total transglutaminase used in 2023, mainly used by the meat processing industry.

Asia-Pacific is the biggest and growing market due to the rising rates of urbanization, higher disposable income, and a growing middle income earners market. Overall, the Asia-Pacific region, which includes India and China, recorded an average annual growth rate of 8.5 % for transglutaminase consumption in the period 2020 to 2023 due in part to the convenience foods market.

 

Key Players

• Ajinomoto Co., Inc.

• Jiangsu Yiming Biological Technology Co., Ltd.

• TCI America

• Pangbo Biological

• C & P Nutrition Pte Ltd

• Micro-Tech Foods Ingredients

• AB Enzymes

• Amano Enzyme Inc.

• Kinry Food Ingredients

• Taixing Dongsheng Food Technology Co., Ltd.

 

Future Outlook

The Transglutaminase market is expected to experience rapid growth in the future, attributable to the increasing demand for TGases from the food industry, the increasing usage of TGases in the pharmaceuticals and cosmetics sectors, and advances in enzyme procurement. New Opportunities are in Latin America, Asia-Pacific, and the Middle East and Africa, while North America and Europe will have the highest innovation and application use.

 

The growth of sustainable production practices and the creation of new applications in industry, such as tissue engineering and drug delivery, will define the future of the market. The industry's major players are expected to invest in areas like research and development along with strategic partnerships so as to aggressively capture the emerging functional segments and cost-sensitive enzyme markets.